Search results for “ET combination” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 95 patents, we discovered top 24 key players by total patent application. ESSA Pharma, Inc., Janpix Holdings, Inc., Genentech, Inc. are dominant in this area. They take 27.37% of the total patent filing.
ESSA Pharma, Inc.
British Columbia, Canada
Patent: 10
Janpix Holdings, Inc.
Massachusetts, United States
Patent: 8
Genentech, Inc.
California, United States
Patent: 7
F. Hoffmann-La Roche Ltd.
Switzerland
Patent: 6
Eli Lilly & Co.
Indiana, United States
Patent: 3
OncoTherapy Science, Inc.
Kanagawa-ken, Japan
Patent: 3
Astellas Pharma, Inc.
Tokyo-to, Japan
Patent: 2
Io Therapeutics, Inc.
California, United States
Patent: 2
Ionis Pharmaceuticals, Inc.
California, United States
Patent: 2
Pfizer Inc.
New York, United States
Patent: 1
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 86 patents applied in the last 5 years. We discover 27 most active companies in this area. The fast-growing ESSA Pharma, Inc., Janpix Holdings, Inc., Dana-Farber Cancer Institute, Inc. take 29.07% of patent filing during this period.
ESSA Pharma, Inc.
British Columbia, Canada
Patent: 10
Janpix Holdings, Inc.
Massachusetts, United States
Patent: 8
Dana-Farber Cancer Institute, Inc.
Massachusetts, United States
Patent: 7
Genentech, Inc.
California, United States
Patent: 6
F. Hoffmann-La Roche Ltd.
Switzerland
Patent: 6
Eli Lilly & Co.
Indiana, United States
Patent: 3
Io Therapeutics, Inc.
California, United States
Patent: 2
Astellas Pharma, Inc.
Tokyo-to, Japan
Patent: 2
Tufts University
Massachusetts, United States
Patent: 2
University of British Columbia
British Columbia, Canada
Patent: 2
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 86 patents in last 5 years, we discover 21 new entrants. ESSA Pharma, Inc., Janpix Holdings, Inc., F. Hoffmann-La Roche Ltd. are the most active new entrants in this area.
ESSA Pharma, Inc.
British Columbia, Canada
Patent: 10
Janpix Holdings, Inc.
Massachusetts, United States
Patent: 8
F. Hoffmann-La Roche Ltd.
Switzerland
Patent: 6
Eli Lilly & Co.
Indiana, United States
Patent: 3
Astellas Pharma, Inc.
Tokyo-to, Japan
Patent: 2
University of British Columbia
British Columbia, Canada
Patent: 2
Io Therapeutics, Inc.
California, United States
Patent: 2
Gilead Sciences, Inc.
California, United States
Patent: 1
University of Freiburg
Baden-Württemberg, Germany
Patent: 1
The National Centre For Cell Sciences
Maharashtra, India
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 19 patents, we discovered top 5 universities and scientific research institutions by total patent application. Tufts University, University of British Columbia, University of Kansas Medical Center are dominant in this area. They take 42.11% of the total patent filing.
Tufts University
Massachusetts, United States
Patent: 3
University of British Columbia
British Columbia, Canada
Patent: 2
University of Kansas Medical Center
United States
Patent: 1
University of Freiburg
Baden-Württemberg, Germany
Patent: 1
Qingdao Agriculture University
Shandong Sheng, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: